Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus

Eldrin F. Lewis, Brian Claggett, Patrick S. Parfrey, Emmanuel A. Burdmann, John J V McMurray, Scott D. Solomon, Andrew S. Levey, Peter Ivanovich, Kai Uwe Eckardt, Reshma Kewalramani, Robert Toto, Marc A. Pfeffer

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Background The incidence of end-stage renal disease (ESRD) has been consistently shown to be higher among blacks and Hispanics compared to whites with unmeasured risk factors and access to care as suggested explanations. In a high-risk cohort with frequent protocol-directed follow-up, we evaluated the influence of race on cardiovascular (CV) outcomes and incidence of ESRD. Methods TREAT was a randomized, double-blind, placebo-controlled study. This secondary analysis focused on role of race on outcomes. TREAT enrolled 4,038 patients with type 2 diabetes, chronic kidney disease (estimated glomerular filtration rate 20-60 mL/min per 1.73 m2), and anemia (hemoglobin level>1 g/dL) treated with either darbepoetin alfa or placebo. We compared self-described black and Hispanic patients to white patients with regard to baseline characteristics and outcomes, including mortality, CV outcomes (myocardial infarction, stroke, heart failure, resuscitated sudden death, and coronary revascularization), and incident ESRD. Multivariate adjusted Cox models were developed for these outcomes. Results Black and Hispanic patients were younger, more likely women, had less prior CV disease, and higher blood pressure. During a mean follow-up of 2.4 years with comparable access to care, blacks and Hispanics had a greater risk of ESRD but a significant lower risk of myocardial infarction and coronary revascularization than whites. After adjusting for confounders, blacks remained at significantly greater risk of ESRD than whites (hazard ratio 1.53, 95% CI 1.26-1.85, P <.001), whereas this ESRD risk did not persist among Hispanics. Conclusion Despite similar access to care and lower CV event rates, the risk of ESRD was higher among blacks and Hispanics than whites. For blacks, but not Hispanics, this increase was independent of known attributable risk factors.

Original languageEnglish (US)
Pages (from-to)322-329.e4
JournalAmerican heart journal
Issue number2
StatePublished - Aug 1 2015

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus'. Together they form a unique fingerprint.

Cite this